Daphne Karydas

Insider Reports History

Entity
Individual
Location
35 Gatehouse Drive, Building D, Floor 3, Waltham, MA
Signature
/s/ Adam Levy, Attorney-in-fact
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Daphne Karydas:

Stock Role Class Num Shares Value Price $ Report Date Ownership
COMPASS Pathways plc Director Share Option (Right to Buy) 26K May 9, 2024 Direct
Mineralys Therapeutics, Inc. Director Stock Option 22K May 22, 2024 Direct
LogicBio Therapeutics, Inc. Director Stock Option (right to buy) 0 Nov 16, 2022 Direct

Insider Reports Filed by Daphne Karydas

Symbol Company Period Transactions Value $ Form Type Date Filed Role
MLYS Mineralys Therapeutics, Inc. May 22, 2024 1 $0 4 May 23, 2024 Director
CMPS COMPASS Pathways plc May 9, 2024 1 $0 4 May 13, 2024 Director
CMPS COMPASS Pathways plc Sep 18, 2023 1 $0 4 Sep 20, 2023 Director
CMPS COMPASS Pathways plc Sep 18, 2023 0 $0 3 Sep 20, 2023 Director
MLYS Mineralys Therapeutics, Inc. Sep 13, 2023 0 $0 3 Sep 14, 2023 Director
MLYS Mineralys Therapeutics, Inc. Sep 13, 2023 1 $0 4 Sep 14, 2023 Director
LOGC LogicBio Therapeutics, Inc. Nov 16, 2022 1 $0 4 Nov 17, 2022 Director
LOGC LogicBio Therapeutics, Inc. Jun 17, 2022 1 $0 4 Jul 5, 2022 Director
LOGC LogicBio Therapeutics, Inc. Jun 11, 2021 1 $0 4 Jun 14, 2021 Director